NEW YORK (GenomeWeb) – Linkage Biosciences today announced a distribution partnership with Voden Medical Instruments.

The deal gives Voden rights to distribute Linkage's genetic testing, including the real-time PCR-based LinkSeq human leukocyte antigen (HLA) test.

"Voden Medical possesses a long standing record of excellent customer service and proven technical expertise, particularly in the area of HLA testing," Linkage Biosciences CEO Zachary Antovich said in a statement.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.